SCRI-Tennessee Oncology — Nashville, Tennessee

SCRI-Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI-Tennessee Oncology has participated in 22 clinical trials with 3 currently active.

Therapeutic areas: Pancreatic Cancer, Solid Tumors, Renal Cell Carcinoma.

Sponsors: Merrimack Pharmaceuticals, EMD Serono Research & Development Institute, Inc., Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI-Tennessee Oncology?

SCRI-Tennessee Oncology has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI-Tennessee Oncology conducted?

SCRI-Tennessee Oncology has 22 clinical trials on record, with 3 currently active. Their work covers Pancreatic Cancer, Solid Tumors, Renal Cell Carcinoma.

Is SCRI-Tennessee Oncology accredited by Crixeo Clinical Trials?

SCRI-Tennessee Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI-Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.